MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,765.36
-0.47%
NASDAQ 100
$30,725.81
-1.39%
DOW JONES
$51,232.00
+0.10%
NASDAQ Composite
$27,193.34
-1.25%
RUSSELL 2000
$2,775.70
-0.05%
CBOE VIX
$15.41
+2.19%
Sector Heatmap
Technology-1.79%
Financials+0.89%
Healthcare-0.39%
Consumer Cycl+0.31%
Consumer Staples+2.11%
Energy+2.97%
Industrials+0.33%
Materials+0.59%
Real Estate+0.69%
Utilities-0.19%
Comm Services+0.73%
RNAC — Cartesian Therapeutics, Inc. Common Stock
NasdaqCartesian Therapeutics, Inc. Common Stock
$6.82
+0.14(+2.10%)
- O
- 6.68
- H
- 6.82
- L
- 6.50
- V
- 161.74K
⏱️ End-of-day dataAs of Oct 8, 2026
RNAC — Latest News & Headlines
7 StoriesFour new hires received the right to buy 121,900 shares at Cartesian Therapeutics - Stock Titan
Four new hires received the right to buy 121,900 shares at Cartesian Therapeutics Stock Titan
Understanding Momentum Shifts in (RNAC) - Stock Traders Daily
Understanding Momentum Shifts in (RNAC) Stock Traders Daily
APP,CCC,RCAT,OPTU,MRKR,INOD,RNAC,OKLO,ARDX,AJG | Stock Prices | Quote Comparison - Yahoo! Finance Canada
APP,CCC,RCAT,OPTU,MRKR,INOD,RNAC,OKLO,ARDX,AJG | Stock Prices | Quote Comparison Yahoo! Finance Canada
Cartesian Therapeutics Reports Positive Retreatment Data for Descartes-08 in Generalized Myasthenia Gravis - Quiver Quantitative
Cartesian Therapeutics Reports Positive Retreatment Data for Descartes-08 in Generalized Myasthenia Gravis Quiver Quantitative
RNAC Nov 2026 12.500 put (RNAC261120P00012500) interactive stock chart - Yahoo Finance Australia
RNAC Nov 2026 12.500 put (RNAC261120P00012500) interactive stock chart Yahoo Finance Australia
Cartesian Therapeutics Announces New Employment Inducement Grants - The Manila Times
Cartesian Therapeutics Announces New Employment Inducement Grants The Manila Times
H.C. Wainwright reiterates Cartesian Therapeutics stock rating at buy By Investing.com - Investing.com UK
H.C. Wainwright reiterates Cartesian Therapeutics stock rating at buy By Investing.com Investing.com UK